《新股消息》辉煌明天(01351.HK)今日起招股 入场费为2,222.17元
内地移动广告公司辉煌明天(01351.HK)公布招股详情,计划发行1.25亿股股份,当中10%在港公开发售,招股价介乎1至1.1元,每手2,000股,入场费为2,222.17元;由今日(28日)至下周一(11月2日)公开招股,预计将於11月11日上市。大有融资为独家保荐人。
公司是次上市引入2名基石投资者,合共认购3,860万元股份。以招股价中位数1.05元计,发售所得款项净额约8,030万元,当中64.9%将用於扩展集团中介服务;21.3%将用於扩展营销、客户服务及设计团队;10.5%用於提升信息技术及数据管理平台系统;以及余下3.3%作为一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.